Feedback / Questions
IGV-001 - Imvax
https://www.businesswire.com/news/home/20251202226166/en/Imvax-Announces-Positive-Top-line-Data-from-Phase-2b-Clinical-Trial-of-IGV-001-in-Newly-Diagnosed-GBM
Dec 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next